what is it worth to cure any virus, to cure sepsis and to cure cancer ?? without the bad side effects of chemo therapy ???? or drugs... ..very interesting company and if real, very revolutionary ......2016 should give some answers .. you pays your money and you takes your chances
wainright can stabilize the price to grease their shelf offerring,, if any is happenning, in the mean time we are moving fast toward news.....darpa and sepsis oct 1,,, the davita study,,, and u of so cal cancer study....even if aemd is a bit overbot it may be worth risk as the upside is substantial in my view... all three could happen in 2016 and it is july.... market starts to discount the news and gamble on good news ....no matter to me as I have my shares and hoping for the Carlisle for thanksgiving ...all are invited
don't underestimate the significance of selling 2 million shares to institutions. this is the 'sponsorship' aethlon has needed. wainright has a top reputation for institutional security research. this may be the beginning for this little company...
maybe it is time for the bashers to cash in the shorts and go away...when wainright brings in institutional investors we could see higher levels.....I need 16 for lunch at the Carlisle, but maybe less.... hhmmmmm dreaming of a Bentley
it is the hands of Wainritght who has the 12 milllion buck underwriting....they are a revered institutional house and noted for research/. as the show this to institutional prospects who buy a minimum of 100,000 shares we are entering a new phase...shorts need to 'get right with God" ....but then they know it all... this is, to jme, a lifetime opportunity, if it succeeds and I have a lot of stock .. if not , uncle shares the loss
thanks I think the Wainright participation will change this situation as aemd will be introduced to the institutional market and they have billions to invest....2016 is the year with all that is happening and the potential is very special. the recent news from Zacks doesnt hurt. I plan to add shares with the momentum players, if they ever show up. In the mean time I am in til the bitter end [or sweet]
what if they place the 2 million shares with 4 institutions at 500,000 shares each??? no more cash problems and validation of the company by institutional buyers????? shorts beware....the game maybe changing
the underwriter is a respected institutional research broker...the institutional buyers will be listed and likely attract interest...i will be interested in seeing their write ups. 12 million should do the trick as I see a going business selling hemopurifiers in large numbers at a tidy profit for each .........2016 is the year for Aethlon...shorts best clean up and take their profit and join us at the carlisle in the fall
down side is protected by the underwriter and we enter a new phase of institutional ownership as the 2 million shares get placed.......patience is being rewarded...I have my shares, do you??? pump and hold???
news today wainright did not get options or warrants and only 3% commission...a hard bargain and very favorable...way to go JJ Joyce ...waintight can always buy shares ...run shorts
wainright , the underwriter has control and can make stabilizing trades.... i expect block trades at 6 level.. shorts are playing with fire as usually the underwriter gets bonus options ......we have waited long enough and with good news coming this year aethlon could be in the limelight . I have my shares and will still invite the bashers to lunch at the carlisle if we reach 16.......but no desert. all the rest are invited of course. aemd shud be on the most advanced lists from today's trading
I wonder if the indexers will take this stock....this offering should provide funds to compete the several initiatives which are well under way .......higher daily volume also helps attract institutions.
I agree ..... either the davita study of darpa...if you think about it aethlon is the first line of defense in bio warfare and that may be closer than we think ......if indexers need 100,000 shares they can tap the shelf offerring